Day: June 7, 2024

Expects to mass produce innovative ultra efficient 5J/TH chips by Q4 2025 with investments in R&D SINGAPORE, June 07, 2024 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (Nasdaq: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for blockchain and high-performance computing, today announced its research & development (R&D) technology roadmap for the SEALMINER Bitcoin mining machine. This disclosure reaffirms the Company’s ongoing commitment towards driving greater transparency in the mining industry. In the dynamically evolving mining market, two aspects of transparency are particularly crucial for miners. Firstly, miners’ expectations of future technological advancements and delivery timelines of mining machines; Secondly, access to data analytics of mining machine capabilities, equipment inventory,...

HONG KONG, June 07, 2024 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it had completed a HKD440 million investment in Gravitation Fintech HK Limited, the parent company of Airstar Bank, a Hong Kong licensed virtual bank. Following the investment, Futu has become the second largest beneficial owner holding indirectly 44.11% of Airstar Bank. About Futu Holdings Limited Futu Holdings Limited (Nasdaq: FUTU) is an advanced technology company transforming the investing experience by offering fully digitalized financial services. Through its proprietary digital platforms, Futubull and moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and...

VANCOUVER, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF), is pleased to announce a non-brokered private placement (the “Offering”) for gross proceeds of up to CAD$30,000,000. HighlightsThe Offering will provide Fireweed with capital to advance its comprehensive 2024 drilling and regional exploration programs at Macpass, as well as support critical path items and financial commitments at Mactung. The Lundin Family Trusts have indicated their intention of subscribing for up to $30.0 million of the Private Placement alongside lead orders from other key shareholders.CEO Statement Peter Hemstead, Interim CEO, stated, “We are pleased to enjoy the continued backing of our key shareholders; their significant involvement in this financing underscores...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin inhibitor HMPL-506 in patients with hematological malignancies in China. The first patient received their first dose on May 31, 2024. This is a Phase I, multicenter, open-label clinical study to evaluate the safety, pharmacokinetics and efficacy of HMPL-506 in patients with hematological malignancies. The study is divided into two phases, a dose escalation phase and a dose expansion phase. The study is expected to enroll at least 60 patients. The lead principal investigators are Dr. Jianxiang Wang and Dr. Hui Wei of Chinese Academy of Medical Sciences Blood Diseases Hospital. Additional details may be found at clinicaltrials.gov,...